Product Information
IMIQUIMOD 3.75% CREAM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $36.3836 per EA under NDC 51672417406. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
37.5 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672417406
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
IMIQUIMODApproval Type
Generic (ANDA)
FDA Application
ANDA205971On Market Since
1/26/2021
Pharmacological Classes
Price Statistics
The NADAC for IMIQUIMOD 3.75% CREAM has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 49.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.3836 per EA |
|---|---|
| All-time high | $36.3836 (Jun 24, 2026) |
| All-time low | $21.6240 (May 21, 2025) |
| 52-week high | $36.3836 |
| 52-week low | $21.7899 |
| Median price | $22.0395 |
| Average price | $22.8773 |
| Largest weekly change | +65.1% (Jun 17, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Imiquimod market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of IMIQUIMOD 3.75% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for IMIQUIMOD 3.75% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $36.3836 per EA (NDC 51672417406), effective Jun 24, 2026.
How has the price of IMIQUIMOD 3.75% CREAM changed over time?
Over the history we have for it, the NADAC for IMIQUIMOD 3.75% CREAM has risen 49.2%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for IMIQUIMOD 3.75% CREAM?
Since Apr 17, 2024, the NADAC for IMIQUIMOD 3.75% CREAM has ranged from a low of $21.6240 (May 21, 2025) to a high of $36.3836 (Jun 24, 2026), with a median of $22.0395 per EA.
Are there cheaper alternatives to IMIQUIMOD 3.75% CREAM?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of IMIQUIMOD 3.75% CREAM, so no direct lower-cost alternative is listed.
Who manufactures IMIQUIMOD 3.75% CREAM?
IMIQUIMOD 3.75% CREAM (NDC 51672417406) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.